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Calmodulin (CaM) inhibits the skeletal muscle ryano-
dine receptor-1 (RyR1) and cardiac muscle RyR2 at mi-
cromolar Ca2 but activates RyR1 and inhibits RyR2 at
submicromolar Ca2 by binding to a single, highly con-
served CaM-binding site. To identify regions responsible
for the differential regulation of RyR1 and RyR2 by
CaM, we generated chimeras encompassing and flank-
ing the CaM-binding domain. We found that the ex-
change of the N- and C-terminal flanking regions differ-
entially affected RyR1 and RyR2. A RyR1/RyR2 chimera
with an N-terminal flanking RyR2 substitution (RyR2
amino acid (aa) 3537–3579) was activated by CaM in
single channel measurements at both submicromolar
and micromolar Ca2. A RyR2/RyR1 chimera with a C-
terminal flanking the 86-amino acid RyR1 substitution
(RyR1 aa 3640–3725) bound 35S-CaM but was not inhib-
ited by CaM at submicromolar Ca2. In this region, five
non-conserved amino acid residues (RyR1 aa 3680 and
3682–3685 and RyR2 aa 3647 and 3649–3652) differen-
tially affect RyR helical probability. Substitution of the
five amino acid residues in RyR1 with those of RyR2
showed responses to CaM comparable with wild type
RyR1. In contrast, substitution of the five amino acid
residues in RyR2 with those of RyR1 showed loss of CaM
inhibition, whereas substitution of the five RyR2 se-
quence residues in the RyR2 chimera containing the
RyR1 calmodulin-binding domain and C-flanking se-
quence restored wild type RyR2 inhibition by CaM at
submicromolar Ca2. The results suggest that different
regions are involved in CaM modulation of RyR1 and
RyR2. They further suggest that five non-conserved
amino acids in the C-terminal region flanking the CaM-
binding domain have a key role in CaM inhibition of
RyR2.
Ca2-release channels, known as ryanodine receptors
(RyR),1 play a key role in a variety of cells by increasing the
cytoplasmic Ca2 concentration in response to cellular signals.
Three different RyR genes have been identified in mammalian
cells: skeletal type (RyR1), cardiac type (RyR2), and brain type
(RyR3) (1–3). The RyRs form large protein complexes composed
of four 565-kDa subunits and four small FK506-binding pro-
teins. Multiple small physiological molecules such as Ca2,
Mg2, and ATP and proteins such as protein kinases and
calmodulin (CaM) modulate RyR ion channel function (1–3).
CaM is a small cytosolic Ca2-binding protein that regulates
various cellular functions (4, 5). Direct CaM binding inhibits all
three RyR isoforms at [Ca2]  1 M, whereas at [Ca2]  1 M
RyR1 and RyR3 are activated, but RyR2 is inhibited by CaM (6,
7). 35S-CaM binding to sarcoplasmic reticulum vesicles (8, 9)
and purified RyR1 and RyR2 (10) showed that the two receptor
isoforms bind one molecule of CaM per RyR subunit in the
absence and presence of Ca2. CaM protection of trypsin diges-
tion of RyR1 (11) and site-directed mutagenesis of RyR1 (12)
and RyR2 (13) demonstrated that the two RyRs have a single
CaM regulatory binding domain (CaMBD) (aa 3614–3643 in
RyR1) for the Ca2-free and Ca2-bound (Ca2-CaM) forms of
CaM. The CaM-binding domain is highly conserved among the
mammalian isoforms, yet corresponding mutations in the RyR1
and RyR2 CaM-binding domain resulted in a different response
to CaM in 35S-CaM binding and functional measurements (13).
This result suggests that other isoform-specific regions are
responsible for the differential modulation of RyR1 and RyR2
by CaM.
To test the hypothesis of an involvement of isoform-specific
regions in regulating RyR1 and RyR2 by CaM, we constructed
a series of RyR1/RyR2 chimeras and determined their CaM-
binding properties and modulation by CaM. The results sug-
gest that multiple regions are involved in transducing the
functional effects of CaM in RyR1 and RyR2. The present study
focused on the role of one of these regions. We found that
substitution of five amino acid residues in RyR2 with those of
RyR1 eliminated CaM inhibition but not CaM binding at
[Ca2]  1 M.
EXPERIMENTAL PROCEDURES
Materials—[3H]Ryanodine was obtained from PerkinElmer Life Sci-
ences, Tran35S-label from ICN Radiochemicals (Costa Mesa, CA), un-
labeled ryanodine from Calbiochem, Complete protease inhibitors from
Roche Applied Science, and HEK293 cells from the American Type
Culture Collection. RyR2 cDNA was kindly provided by Dr. Junichi
Nakai of RIKEN Brain Science Institute (Wako, Japan). Unlabeled
CaM and 35S-CaM were prepared as described previously (10).
Construction of RyR cDNAs—The full-length rabbit RyR1 (14) and
RyR2 (15) cDNAs were subcloned into expression vectors pCMV5 and
pCIneo, respectively. Single and multiple base changes were introduced
by Pfu-turbo polymerase-based chain reaction, using mutagenic oligo-
nucleotides and the QuikChange site-directed mutagenesis kit (Strat-
agene, La Jolla, CA). The complete mutated DNA fragments amplified
by PCR were confirmed by DNA sequencing. A schematic summary and
the amino acid numbers of RyR chimeras are shown in Fig. 1.
To construct RyR2-based chimeras and mutants, a ClaI/SacII-
(10483–11203) fragment of RyR2 was subcloned into pBluescript KS
vector. For RyR1-based chimeras and mutants (except RyR1-10M), an
EclXI/NdeI-(10741–11173) (for 1-2-1, 1-2-1(C), and RyR1-5M) or an
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EclXI/BamHI-(10741–10983) (for 1-2-1(N)) fragment was subcloned
into pBluescript KS vector. The creation of 1-2-1 and 2-1-2 chimeras
involved the use of a common restriction enzyme site (NdeI, 11173 of
RyR1, and 11071 of RyR2) and the introduction of a new site (EclXI) in
RyR2 at a location corresponding to the EclXI site in RyR1. For other
chimeras, additional specific enzyme sites (SphI for 1-2-1(N) and 2-1-
2(N) and NcoI for 1-2-1(C) and 2-1-2(C)) were introduced at correspond-
ing positions in the RyR1 and RyR2 sequences. The aforementioned
EclXI site was also used for obtaining 1-2-1(N) and 2-1-2(N), and EclXI/
SphI and NcoI/NdeI fragments were exchanged for N- and C-terminal
replacements, respectively. After construction of the chimeric frag-
ments, sequences of SphI and NcoI sites were changed back to the
original sequences in order not to cause amino acid changes.
The chimeric ClaI/SacII fragment was subcloned back to the original
position of a vector containing the BbrPI/SacII-(5038–11203) fragment
of RyR2 and then to full-length RyR2 in the pCIneo expression vector to
construct the full-length RyR2-based chimera expression plasmids. The
chimera EclXI/NdeI or EclXI/BamHI fragment was subcloned back to a
vector containing a PvuI/NdeI-(8469–11173) fragment of RyR1 and
then to a vector containing PvuI/XbaI-(8469-polylinker) fragment. Full-
length expression plasmids for RyR1-based chimeras were prepared by
ligation of two fragments (ClaI/PvuI and PvuI/XbaI) and expression
vector pCMV5 (ClaI/XbaI).
To construct RyR1-10M, a vector containing the PinAI/XhoI-(4935–
6467) fragment of RyR1 was used as a template for mutagenesis. The
mutated fragment was subcloned back to a vector containing ClaI/PvuI-
(polylinker-8469), and then a full-length expression plasmid was pre-
pared by 3 fragment ligation as described above. Nucleotide numbering
is as described previously (15, 16).
Expression of Full-length RyRs in HEK293 Cells—RyR cDNAs were
transiently expressed in HEK293 cells with FuGENE 6 (Roche Applied
Science) according to the manufacturer’s instruction. Cells were main-
tained at 37 °C and 5% CO2 in high glucose Dulbecco’s modified Eagle’s
medium containing 10% fetal bovine serum and were plated the day
FIG. 1. Sequence alignment of RyR1 and RyR2 chimeras and their modulation by calmodulin at 0.4 and 2 M Ca2. A, sequences of
rabbit RyR1 (16) and RyR2 (15) CaMBD and N- and C-terminal flanking regions are shown. Chimeras 1-2-1 and 1-2-1(N) contain a 43-amino acid
RyR2 substitution (aa 3537–3579), whereas chimeras 2-1-2 and 2-1-2(N) contain a 32-amino acid RyR1 substitution (aa 3581–3612). 5M, mutated
region in RyR1-5M and RyR2-5M; N and C, substituted regions in RyR1/RyR2 chimeras. B, schematic representation of RyR1-based (right panel)
and RyR2-based (left panel) chimeras and mutants and their modulation by CaM. Open bars, RyR1 sequences; shaded bars, RyR2 sequences.
Channel open probabilities are shown on the right of panels. Data show the relative mean channel open probability (Po,CaM  100%)  S.E. of
4–15 single channel recordings at 0.4 M Ca2 plus 1 mM ATP (RyR1 only) (open bars) and 2 M Ca2 (filled bars) in the presence of 50 nM (upper
open and filled bars) and 1 M (lower open and filled bars) CaM. *, p  0.05 compared with control (CaM).
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before transfection. For each 10-cm tissue culture dish, 3.5 g of cDNA
was used. Cells were harvested 48 h after transfection, and crude
membrane fractions were prepared as described previously (12).
35S-Calmodulin Binding—Crude membrane fractions of HEK293
cells were incubated for 2.5 h at room temperature with 15–200 nM
35S-CaM in 20 mM imidazole, pH 7.0, 0.15 M sucrose, 150 mM KCl, 0.1
mg/ml bovine serum albumin, 5 mM glutathione (reduced), 25 M leu-
peptin, 250 M Pefabloc, and either 5 mM EGTA, 0.4 M Ca2, or 100 M
Ca2. Aliquots were taken for determination of total radioactivity and
centrifuged for 30 min at 90,000  g in a Beckman Airfuge to obtain
bound 35S-CaM. Radioactivity levels were determined by scintillation
counting. Nonspecific binding of 35S-CaM was determined by incubat-
ing equal amounts of protein derived from vector-transfected HEK293
cells.
In parallel experiments, Bmax values of [
3H]ryanodine binding were
determined by incubating membranes at room temperature with a
saturating concentration of [3H]ryanodine (40 nM) in 20 mM imidazole,
pH 7.0, 0.6 M KCl, 0.15 M sucrose, 25 M leupeptin, 250 M Pefabloc, and
200 M Ca2. Nonspecific binding was determined using a 1000–2000-
fold excess of unlabeled ryanodine. After 5 h, samples were diluted with
8 volumes of ice-cold water and placed on Whatman GF/B filters pre-
incubated with 2% polyethyleneimine in water. Filters were washed
three times with 5 ml of ice-cold 100 mM KCl, 1 mM KPipes, pH 7.0,
solution. The radioactivity remaining with the filters was determined
by liquid scintillation counting to obtain the amount of bound
[3H]ryanodine.
Single Channel Analysis—Single channel measurements of WT and
mutant RyRs were performed in planar lipid bilayers containing phos-
phatidylethanolamine, phosphatidylserine, and phosphatidylcholine in
the ratio of 5:3:2 (25 mg of total phospholipid/ml of n-decane) as de-
scribed previously (13). Crude membrane fractions expressing WT and
mutant RyRs were pretreated for 30 min at room temperature with 1
M myosin light chain kinase-derived CaM-binding peptide to dissoci-
ate endogenous CaM (10). Final peptide concentration was 10 nM
following the addition of membranes to the cis (cytosolic) chamber of the
bilayer apparatus. A strong dependence of single channel activities on
cis-Ca2 concentration indicated that the large cytosolic “foot” region
faced the cis chamber of the bilayers. The trans (lumenal) side of the
bilayer was defined as ground. Measurements were made with sym-
metrical 0.25 M KCl, 20 mM KHepes, pH 7.4, with 0.4 M or 2 M free
Ca2 in the cis chamber. Single channel recordings with WT-RyR1 and
chimeras were made in the presence of 0.4 M Ca2 and 1 mM ATP to
increase the otherwise very low channel activities. Exogenous CaM was
added to the cis solution. Electrical signals were filtered at 2 kHz,
digitized at 10 kHz, and analyzed as described previously (17). Po values
in multichannel recordings were calculated using the equation Po 
	 iPo,i/N, where N is the total number of channels, and Po,i is channel
open probability of the ith channel.
Biochemical Assays and Data Analysis—Free Ca2 concentrations
were obtained by including in the solutions the appropriate amounts of
Ca2 and EGTA as determined using the stability constants and com-
puter program published by Shoenmakers et al. (18). Free Ca2 con-
FIG. 2. 35S-CaM binding to WT-
RyR2, RyR2-based chimeras, and mu-
tants. Membrane fractions prepared from
HEK293 cells expressing WT-RyR2, RyR
chimeras, and mutants were incubated
for 2.5 h at room temperature with indi-
cated concentrations of 35S-CaM in the
presence of  10 nM Ca2 (top), 0.4 M
Ca2 (middle), and 100 M Ca2 (bottom).
The ratios of 35S-CaM binding values to
maximal binding values of [3H]ryanodine
were obtained, taking into account that
there is one high affinity [3H]ryanodine-
binding site per RyR2 tetramer. Data are
the mean  S.E. of 3–13 experiments.
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centrations of 1 M were verified with the use of a Ca2-selective
electrode. Results are given as mean  S.E. Significance of differences
in the data (p  0.05) was determined using Student’s t test.
RESULTS
To identify the isoform-specific regions involved in CaM mod-
ulation, we prepared 10 RyR1- and RyR2-based chimeras and
multisite mutants (Fig. 1B) and transiently expressed them in
HEK293 cells. All chimeras and mutants showed a Ca2 de-
pendence of [3H]ryanodine binding corresponding to that of
WT-RyR1 or WT-RyR2 (19).
35S-CaM Binding of RyR2-based Chimeras and Mutants—
The ability of RyR2-based chimeras and mutants to bind CaM
was investigated by a centrifugation assay. Three different
concentrations of metabolically labeled 35S-CaM were used at
three different Ca2 concentrations of 5 mM EGTA (Ca2-free),
0.4 M free Ca2 (a Ca2 concentration that results in activa-
tion of RyR1 but inhibition of RyR2 by CaM (10)), and 100 M
Ca2 (Ca2-CaM). The Bmax values of [
3H]ryanodine binding
were determined in parallel experiments to determine RyR
protein expression levels. Fig. 2 shows that WT-RyR2 bound
35S-CaM in a concentration-dependent manner. WT-RyR2
bound 2.0  0.3 35S-CaM per high affinity [3H]ryanodine-bind-
ing site at 200 nM CaM and  10 nM Ca2, which corresponds
to 0.5 CaM per RyR2 subunit because there is only one high
affinity [3H]ryanodine-binding site per RyR2 tetramer. Higher
saturating CaM concentrations were not used because these
resulted in high background binding levels. The mean numbers
of bound 35S-CaM per RyR2 subunit were 0.6 at 200 nM CaM
and 0.4 M Ca2 and 0.9 at 75 nM CaM and 100 M Ca2 (Fig.
2), which were in good agreement with values reported previ-
ously (13). Fig. 2 also shows that all RyR2-based chimeras and
mutants (Fig. 1B, left panel) examined in this study bound
35S-CaM. Some differences in the binding levels were observed;
however, none of these were significantly different from WT-
RyR2. The expression levels of RyR1-based chimeras and mu-
tants (Fig. 1B, right panel) were too low to determine their
CaM binding levels. The Bmax values of [
3H]ryanodine binding
were 
0.1–0.2 pmol/mg of protein, compared with 0.5
pmol/mg for RyR2-based chimeras.
CaM Modulation of RyR2-based Chimeras and Mutants—
Fig. 3 compares the modulation of WT-RyR1 and WT-RyR2 by
50 nM and 1 M CaM with that of chimera 2-1-2 in the presence
of 0.4 M and 2 M cytosolic free Ca2. Chimera 2-1-2 has a
region of 145 amino acid residues composed of the RyR1
CaMBD and RyR1 N- and C-terminal flanking regions (Fig. 1).
2-1-2 was inhibited by CaM at 2 M Ca2, in accordance with
an inhibition of WT-RyR1 and WT-RyR2 by CaM at [Ca2]  1
M. At 0.4 M Ca2, CaM had no significant effect on the
chimera. 2-1-2 was activated by 50 nM and 1 M CaM in 6 of 15
and 5 of 13 single channel recordings and inhibited in 5 of 15
and 7 of 13 recordings, respectively. In the remaining channel
recordings, CaM was without an effect. The results suggest
that regions encompassing and flanking the CaMBD have a
role in CaM modulation of the RyRs.
To identify the region that was responsible for loss of a
significant effect of calmodulin on 2-1-2 at 0.4 M Ca2, the
chimeric region was subdivided into an N-terminal flanking
(2-1-2(N)), CaM-binding, and C-terminal flanking (2-1-2(C))
region. As described in a previous study (13), substitution of the
four non-identical amino acids in the RyR2 CaM-binding do-
main (Fig. 1A) with the corresponding amino acids in RyR1
yielded results essentially identical to WT-RyR2. Replacement
of the N-terminal flanking region (2-1-2(N)) also did not alter
CaM inhibition at 0.4 M and 2 M Ca2 (Fig. 1B). In contrast,
exchange of the C-terminal flanking region (2-1-2(C)) elimi-
nated CaM inhibition at 0.4 M Ca2 and significant inhibition
at 2 M Ca2 by 50 nM (but not by 1 M) CaM, notwithstanding
that 2-1-2(C) bound 35S-CaM with an affinity comparable with
WT-RyR2.
The N- and C-terminal flanking regions of RyR1 and RyR2
have a sequence identity of 41 and 63%, respectively, compared
with 86% for the CaMBD. Secondary structure predictions,
using a protein sequence analysis program (bmerc-www.
bu.edu/psa/) (20) indicated a nearly indistinguishable helical
probability for the RyR1 and RyR2 CaMBDs (Fig. 4A). In con-
trast, major differences were predicted for both the N-flanking
and C-flanking regions. The differences in helical probability of
N-terminal flanking regions are caused to a large extent by an
RyR2-specific insert (RyR2 aa 3564–3575). We previously
showed that an RyR2 mutant lacking this insert bound 35S-
CaM and was inhibited by CaM in a manner essentially iden-
tical to WT-RyR2 (13). Therefore, this region does not appear to
have a major role in CaM modulation of RyR2. In the C-
terminal flanking region, protein sequence analysis predicted
several differences in helical probability. In the present study,
we address the role of five non-conserved RyR amino acid
residues (RyR2 aa 3647 and 3649–3652) that have a profound
effect on helical probability. Substitution of these five amino
acid residues with those of RyR1 in RyR2 (RyR2–5M) increased
helical probability close to that in RyR1 (Fig. 4B). Single chan-
FIG. 3. Effects of CaM on WT-RyR1, WT-RyR2, and 2-1-2 chi-
mera ion channels. Membrane fractions prepared from HEK293 cells
expressing WT-RyR1 (A), WT-RyR2 (B), or 2-1-2 (C) were fused with a
lipid bilayer. Single channel currents were recorded at 20 mV (c,
downward deflections from closed level) in symmetric 0.25 M KCl, 20
mM KHepes, pH 7.4, medium with 0.4 M Ca2 and 1 mM ATP (WT-
RyR1) or 0.4 M Ca2 (WT-RyR2 and 2-1-2) (left panels) or 2 M Ca2
(right panels) in the cis chamber before (top traces) and after the
addition of 50 nM CaM (middle traces) and 1 M CaM (bottom traces).
Data of 4–15 single channel recordings are summarized in Fig. 1B.
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nel measurements showed a loss of inhibition by CaM at 0.4 M
Ca2 (Figs. 1B and 5A). A role of the five amino acid residues in
CaM inhibition of RyR2 was further assessed by substituting
the five RyR1 amino acids in 2-1-2 and 2-1-2(C) with those of
RyR2. Substitution restored CaM inhibition at 0.4 M Ca2 in
2-1-2(C)rev5M but not 2-1-2rev5M (Figs. 1B and 5, B and C).
The difference in the ability of the five RyR2 amino acids to
restore CaM inhibition was likely the result of the presence of
the N-flanking RyR1 region in 2-1-2, because this region con-
tributes to CaM modulation of RyR1 as described below. At 2
M Ca2, RyR2–5M, 2-1-2rev5M, and 2-1-2(C)rev5M were in-
hibited by CaM (Figs. 1B and 5); however, inhibition was only
significant at 1 M CaM and not 50 nM CaM (Fig. 1B), which
indicated a decreased efficacy of CaM in modulating the mu-
tant channels.
CaM Modulation of RyR1-based Chimeras and Mutants—We
also constructed and expressed four RyR1-based reverse chi-
meras and mutants, 1-2-1, 1-2-1(N), 1-2-1(C), and RyR1-5M.
Characterization of RyR1-based chimeras relied on single
channel recordings because their expression levels were too low
to determine 35S-CaM binding levels (see above). CaM failed to
either activate or inhibit the 1-2-1 chimera (Fig. 1B). Replace-
ment of only the N-terminal flanking region decreased the
efficacy of CaM activation at 0.4 M Ca2 and, surprisingly, at
2 M Ca2 resulted in significant activation of 1-2-1(N) follow-
ing the addition of 1 M CaM. In contrast, replacement of the
C-terminal region failed to disrupt CaM modulation of 1-2-1(C)
at either Ca2 concentration. Substitution of the five amino
acid residues in RyR1 with those of RyR2 decreased helical
probability (Fig. 4B) without affecting CaM activation and in-
hibition of RyR1-5M (Fig. 1B), which was consistent with the
results of 1-2-1(C). Interestingly, at 0.4 M Ca2, CaM acti-
vated RyR1-5M to a greater extent than WT-RyR1 (average
open probability in the presence of 1 M CaM was 1609  450%
(n  4) of control, compared with WT-RyR1 at 295  52%).
Taken together, substitution of the N- and C-terminal flanking
regions appeared to differentially affect RyR2 and RyR1. Fur-
thermore, substitution of five non-conserved amino acid resi-
dues in the C-terminal flanking region resulted in impairment
of CaM modulation of the RyR2-5M mutant, without disrupting
CaM modulation of the RyR1-5M mutant.
Role of RyR1 Amino Acid Residues 1975–1999—Recent tryp-
sin digestion studies and CaM-binding experiments with RyR1
peptides indicate that the carboxyl-terminal half of CaM binds
to the RyR1 CaM-binding domain, whereas the N-terminal half
interacts with RyR1 amino acid residues 1975–1999 (21). There
FIG. 4. Helical probabilities of CaMBD and N- and C-terminal flanking regions. A, helical probabilities of CaM-binding and flanking
regions of RyR1 (filled circle) and RyR2 (open circle) are shown. Each value was calculated from computer program protein sequence analysis (20).
N and C, substituted regions in RyR1 and RyR2. B, helical probabilities of RyR1 (solid line), RyR2 (dotted line), RyR1-5M (filled squares), and
RyR-5M (open squares) are shown.
FIG. 5. Effects of CaM on RyR2-5M, 2-1-2(C)rev5M, and 2-1-
2rev5M ion channels. Single channel currents of RyR2-5M (A), 2-1-
2(C)rev5M (B), and 2-1-2rev5M (C) were recorded as in Fig. 3 at 20
mV (c, downward deflections from closed level) in symmetric 0.25 M KCl,
20 mM KHepes, pH 7.4, medium with 0.4 M Ca2 (left panels) or 2 M
Ca2 (right panels) in the cis chamber before (top traces) and after the
addition of 50 nM CaM (middle traces) and 1 M CaM (bottom traces). Data
of 4–10 single channel recordings are summarized in Fig. 1B.
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are 10 non-identical RyR1 and RyR2 amino acid residues in
this region. We substituted the 10 aa residues in RyR1 with the
corresponding RyR2 residues. The RyR1-10M mutant was ac-
tivated and inhibited by CaM in single channel (Fig. 6) and
[3H]ryanodine binding (not shown) measurements that were
essentially identical to WT-RyR1, which suggests that this
region is not responsible for the differential regulation of RyR1
and RyR2 by CaM at [Ca2]  1 M.
DISCUSSION
Cryomicroscopy studies revealed that the CaM-binding site
in the skeletal muscle RyR isoform is at least 10 nm away from
the effector site (pore) and that Ca2 binding causes an 
33-Å
shift of the binding site (22). Therefore, long range conforma-
tional changes are likely involved in the modulation of RyR
activity by CaM. RyR1 and RyR2 each have a single highly
conserved CaM-binding region; however, the two RyR isoforms
are differentially regulated by CaM, which suggests that iso-
form-specific regions are involved in transducing the functional
effects of CaM. In the present study, we identified one of these
regions. Secondary structure predictions indicated a large dif-
ference between the helical probability of five non-conserved
amino acid residues in the C-terminal region flanking the CaM-
binding domain of RyR1 and RyR2. Substitution of the five
amino acid residues in RyR2 with those of RyR1 eliminated
CaM inhibition at submicromolar Ca2 and decreased the effi-
cacy of CaM inhibition at micromolar Ca2. Conversely, sub-
stitution of the corresponding RyR2 amino acid residues in
RyR1 was without effect on CaM activation and CaM inhibition
at Ca2 concentrations below and above 1 M, respectively.
Thus, five amino acid residues in the C-terminal region flank-
ing the CaM-binding domain appear to have a specific role in
CaM modulation of RyR2.
The RyR2-based chimeras were characterized in 35S-CaM
binding and single channel measurements. Characterization of
RyR1-based chimeras relied on single channel measurements
because expression levels were too low to obtain reliable 35S-
CaM binding data. Although all RyR2-based constructs bound
35S-CaM, regardless of whether the constructs contained the
RyR1 or RyR2 CaMBD, 2-1-2, 2-1-2(C), and RyR2-5M were
unable to convert CaM binding into a functional signal. Inter-
estingly, loss of function was confined to [Ca2]  1 M because
CaM inhibition was observed at [Ca2]  1 M. We also note
that the “uncoupled” constructs had a K conductance and
Ca2 dependence of [3H]ryanodine binding comparable with
WT-RyR2. The results suggest disruption of the interactions of
the CaMBD with protein domains that transduce the func-
tional effects of CaM in RyR2 at [Ca2]  1 M.
Ikemoto and Yamamoto (23) have shown that exogenously
added RyR1 synthetic peptides alter channel activity by “un-
zipping” interdomain interactions in the large RyR1 channel
complex. RyR1 mutations giving rise to malignant hyperther-
mia were suggested to result in elevated channel activities by
disrupting interdomain interactions. Zhu et al. (24) found that
synthetic peptides corresponding to the CaMBD affect RyR1
channel function, which suggested that the exogenously added
peptides bound to a region that directly interacts with the
CaMBD. Previously, we presented evidence for the importance
of three amino acid residues in this interaction in RyR2. Three
mutations in the RyR2 CaMBD (W3587A, L3591D, and
F3603A) eliminated CaM inhibition at 0.4 M Ca2, without an
effect on CaM binding (13). The present work extends the
previous studies by providing the first clues regarding the
identity of regions that transduce the functional effects of CaM
in RyR1 and RyR2
Analysis revealed that substitution of five non-conserved
RyR1 amino acid residues in 2-1-2(C) restored CaM inhibition
at [Ca2]  1 M. On the other hand, substitution of the five
RyR1 residues in 2-1-2 did not restore CaM inhibition. Thus,
the additional presence of the N-terminal region likely intro-
duced conformational changes that could not be reversed by
replacing the five amino acid residues in 2-1-2rev5M. We also
tested the role of the two regions flanking the CaMBD in RyR1.
Chimera 1-2-1 was not modulated by CaM, in contrast to chi-
mera 2-1-2, which was inhibited at [Ca2]  1 M. Further
analysis showed that exchange of only the C-terminal flanking
region did not eliminate CaM activation and CaM inhibition in
the RyR1-based chimera 1-2-1(C), whereas CaM inhibition of
2-1-2(C) was disrupted at [Ca2]  1 M. Opposite effects were
observed when the N-terminal flanking region was exchanged
in RyR1 and RyR2. Replacement of this region did not interfere
with CaM inhibition in 2-1-2(N). The efficacy of CaM activation
of 1-2-1(N) was reduced at 0.4 M Ca2 and unexpectedly
resulted in CaM activation of 1-2-1(N) at 2 M Ca2. Further
studies will be required to determine whether the structural
elements responsible for activation of 1-2-1(N) lie within the
N-terminal flanking region.
Zhang et al. (21) suggested that the carboxyl-terminal half of
CaM binds to the RyR1 CaM-binding domain, whereas the
N-terminal half interacts with RyR1 amino acid residues 1975–
1999. We substituted the 10 non-identical amino acid residues
in RyR1 with the corresponding RyR2 residues and found that
FIG. 6. Effects of CaM on WT-RyR1 and RyR1-10M ion chan-
nels. A, sequences of putative N-lobe CaM-binding region of rabbit
RyR1 sequence (aa 1975–1999) (21) and corresponding rabbit RyR2 (aa
1942–1966) are shown. Sequences and numbering are from References
15 and 16. B and C, single channel activities of WT-RyR1 and RyR1-
10M were determined as described in Fig. 3 in the presence of 0.4 M
Ca2 and 1 mM ATP (B) or 2 M Ca2 (C) in the absence (filled bars) or
presence of 50 nM (shaded bars) and 1 M (open bars) CaM. Normalized
single channel activities are the mean  S.E. of 4–5 experiments. *, p 
0.05 compared with control (CaM).
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the mutant was regulated by CaM essentially identical to WT-
RyR1, which suggests that this region is not responsible for the
differential regulation of RyR1 and RyR2 by CaM at [Ca2] 
1 M.
Our data show that the 1-2-1 chimera was not inhibited by
CaM, notwithstanding that the chimera contained the RyR2
CaMBD and N- and C-terminal flanking regions. Chimera
2-1-2 was not significantly activated at [Ca2]  1 M Ca2,
despite the presence of the RyR1 CaMBD and flanking regions.
These results suggest that additional regions are involved in
the CaM modulation of RyR1 and RyR2, as expected consider-
ing the large size of the RyRs.
In summary, our structure-function analysis shows that it is
possible to use chimeras and multiple site mutants to define
the Ca2-dependent and isoform-dependent regulation of RyR1
and RyR2 by CaM. The chimeras described here formed chan-
nels with a Ca2 dependence and K conductance comparable
with WT-RyRs, which suggests that our structural manipula-
tions did not introduce major global conformational changes,
and thus can reveal regions that have a role in the Ca2-de-
pendent and isoform-dependent CaM modulation of RyR1 and
RyR2. Our work points to one of these regions consisting of five
amino acid residues in the C-terminal flanking region of the
CaMBD of the RyR2 ion channel.
REFERENCES
1. Franzini-Armstrong, C., and Protasi, F. (1997) Physiol. Rev. 77, 699–729
2. Fill, M., and Copello, J. A. (2002) Physiol. Rev. 82, 893–922
3. Meissner, G. (2002) Front. Biosci. 7, d2072–2080
4. Rhoads, A. R., and Friedberg, F. (1997) FASEB J. 11, 331–340
5. Saimi, Y., and Kung, C. (2002) Annu. Rev. Physiol. 64, 289–311
6. Balshaw, D. M., Yamaguchi, N., and Meissner, G. (2002) J. Membr. Biol. 185,
1–8
7. Tang, W., Sencer, S., and Hamilton, S. L. (2002) Front. Biosci. 7, d1583–1589
8. Moore, C. P., Rodney, G., Zhang, J. Z., Santacruz-Toloza, L., Strasburg, G., and
Hamilton, S. L. (1999) Biochemistry 38, 8532–8537
9. Fruen, B. R., Bardy, J. M., Byrem, T. M., Strasburg, G. M., and Louis, C. F.
(2000) Am. J. Physiol. 279, C724–C733
10. Balshaw, D. M., Xu, L., Yamaguchi, N., Pasek, D. A., and Meissner, G. (2001)
J. Biol. Chem. 276, 20144–20153
11. Moore, C. P., Zhang, J. Z., and Hamilton, S. L. (1999) J. Biol. Chem. 274,
36831–36834
12. Yamaguchi, N., Xin, C., and Meissner, G. (2001) J. Biol. Chem. 276,
22579–22585
13. Yamaguchi, N., Xu, L., Pasek, D. A., Evans, K. E., and Meissner, G. (2003)
J. Biol. Chem. 278, 23480–23486
14. Gao, L., Tripathy, A., Lu, X., and Meissner, G. (1997) FEBS Lett. 412, 223–226
15. Nakai, J., Imagawa, T., Hakamata, Y., Shigekawa, M., Takeshima, H., and
Numa, S. (1990) FEBS Lett. 271, 169–177
16. Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa, K.,
Minamino, N., Matsuo, H., Ueda, M., Hanaoka, M., Hirose, T., and Numa,
S. (1989) Nature 339, 439–445
17. Gao, L., Balshaw, D., Xu, L., Tripathy, A., Xin, C., and Meissner, G. (2000)
Biophys. J. 79, 828–840
18. Schoenmakers, T. J., Visser, G. J., Flick, G., and Theuvenet, A. P. R. (1992)
BioTechniques 12, 870–879
19. Nakai, J., Gao, L., Xu, L., Xin, C., Pasek, D. A., and Meissner, G. (1999) FEBS
Lett. 459, 154–158
20. Stultz, C. M., Nambudripad, R., Lathrop, R. H., and White, J. V. (1997) in
Protein Structural Biology in Bio-Medical Research (Allewell, N., and
Woodward, C., eds) Vol. 22B, pp. 447–506, JAI Press, Greenwich, CT
21. Zhang, H., Zhang, J. Z., Danila, C. I., and Hamilton, S. L. (2003) J. Biol. Chem.
278, 8348–8355
22. Samso, M., and Wagenknecht, T. (2002) J. Biol. Chem. 277, 1349–1353
23. Ikemoto, N., and Yamamoto, T. (2002) Front. Biosci. 7, d671–683
24. Zhu, X., Ghanta, J., Walker, J. W., Allen, P. D., and Valdivia, H. H. (2004) Cell
Calcium 35, 165–177
RyR Region Involved in CaM Modulation 36439
